ESC 365 - Feasebility and limitations of early and accelerated therapy following acute decompensated heart failure

Open Access

Feasebility and limitations of early and accelerated therapy following acute decompensated heart failure

Session: Guideline recommended treatment in acute heart failure

Topic: Pharmacotherapy

Speaker: Doctor G. Marino (Rome, IT)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Doctor Gaetano Marino

San Filippo Neri Hospital, Rome (Italy)

2 presentations

0 follower

5 more presentations in this session

The applicability of finerenone therapy across the broad spectrum of cardiovascular-kidney-metabolic syndrome: shaken not stirred

Speaker: Doctor B. Muk (Budapest, HU)

Up-titration of mineralocorticoid receptor antagonists across the ejection fraction spectrum following hospitalization for acute heart failure

Speaker: Doctor G. Filiberti (Milan, IT)

A reason for optimism: opportunities for early initiation of evidence-based therapy in patients with acute heart failure

Speaker: Assistant Professor V. Medovchshikov (Aktobe, KZ)

Mineralocorticoid receptor antagonists dose across the ejection fraction spectrum during hospitalization for acute heart failure

Speaker: Doctor A. Giaj Levra (Rozzano, IT)

Use of non-diuretic pharmacological heart failure therapies in advanced heart failure patients with persistent congestion treated with sustained low-efficiency dialysis

Speaker: Doctor T. Furlan (Trbovlje, SI)

Access the full session

Guideline recommended treatment in acute heart failure

Speakers: Doctor G. Marino, Doctor B. Muk, Doctor G. Filiberti, Assistant Professor V. Medovchshikov, Doctor A. Giaj Levra...

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources